Upper extremity kinematics during functional activities: three-dimensional studies in a normal pediatric population

Kyria Petuskey1, Anita Bagley, Estelle Abdala

  • 1Motion Analysis Laboratory, Shriners Hospitals for Children, Northern California, Sacramento, CA 95817, USA. kpetuskey@shrinenet.org

Gait & Posture
|August 1, 2006
PubMed

Insights

This study establishes a normative pediatric database for 3D upper extremity (UE) motion during activities of daily living (ADLs). This allows for standardized assessment of children with UE functional limitations.

Area of Science:

  • Biomedical Engineering
  • Pediatric Rehabilitation
  • Movement Science

Background:

  • Limited upper extremity (UE) motion affects daily activities in children with various conditions.
  • Three-dimensional (3D) imaging can quantify UE functional limitations but lacks standardized protocols.
  • Defining normal pediatric UE motion is crucial for clinical assessment.

Purpose of the Study:

  • To establish a normative pediatric database of 3D kinematic values for UE motion during activities of daily living (ADLs).
  • To enable quantitative analysis and comparison of functional limitations in children with UE impairments.
  • To facilitate the routine use of 3D imaging techniques in pediatric UE assessment.

Main Methods:

  • Utilized 3D imaging techniques to capture multi-planar UE motion.
  • Defined standard activities and nomenclature for UE movement.
  • Collected kinematic data from a normative pediatric population during selected ADLs.

Main Results:

  • Established a normative database of 3D kinematic values for pediatric UE motion.
  • Provided a benchmark for comparing functional movements in children with UE limitations.
  • Demonstrated the feasibility of using a standardized protocol for UE motion analysis.

Conclusions:

  • The developed protocol and normative database enable standardized 3D assessment of pediatric UE function.
  • This approach facilitates objective comparison of children with UE impairments against a healthy age-matched cohort.
  • Future clinical applications can benefit from this standardized quantitative analysis of functional limitations.